These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 39143009

  • 21. Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
    Ogura T, Tanaka Y, Tamaki H, Harada M.
    Int J Oncol; 2016 Jun; 48(6):2330-8. PubMed ID: 27082738
    [Abstract] [Full Text] [Related]

  • 22. Diospyros rhodocalyx Kurz induces mitochondrial-mediated apoptosis via BAX, Bcl-2, and caspase-3 pathways in LNCaP human prostate cancer cell line.
    Phongsuwichetsak C, Suksrichavalit T, Chatupheeraphat C, Eiamphungporn W, Yainoy S, Yamkamon V.
    PeerJ; 2024 Jun; 12():e17637. PubMed ID: 38966207
    [Abstract] [Full Text] [Related]

  • 23. [Effect of sodium phenylbutyrate on the sensitivity of PC3/DTX-resistant prostate cancer cells to docetaxel].
    Xu YW, Zheng SB, Chen BS, Wen Y, Zhu SW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 37(1):130-134. PubMed ID: 28109113
    [Abstract] [Full Text] [Related]

  • 24. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 25. Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines.
    Karaca B, Degirmenci M, Ozveren A, Atmaca H, Bozkurt E, Karabulut B, Sanli UA, Uslu R.
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1273-80. PubMed ID: 25925002
    [Abstract] [Full Text] [Related]

  • 26. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.
    Feng LX, Li M, Liu YJ, Yang SM, Zhang N.
    Int J Mol Sci; 2014 Mar 10; 15(3):4201-20. PubMed ID: 24619193
    [Abstract] [Full Text] [Related]

  • 27. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM, Lee SY, Cho JS, Son SM, Choi SS, Yun YP, Yoo HS, Yoon DY, Oh KW, Han SB, Hong JT.
    Eur J Pharmacol; 2010 Apr 10; 631(1-3):1-9. PubMed ID: 20056115
    [Abstract] [Full Text] [Related]

  • 28. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.
    Prostate; 2012 Jun 01; 72(8):856-67. PubMed ID: 21968939
    [Abstract] [Full Text] [Related]

  • 29. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 30. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH, Zeng RF, Fang S, Dai QS, Li HP, Long JT.
    Int J Pharm; 2014 Oct 20; 474(1-2):112-22. PubMed ID: 25138252
    [Abstract] [Full Text] [Related]

  • 31. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.
    Xiao D, Singh SV.
    Pharm Res; 2010 Apr 20; 27(4):722-31. PubMed ID: 20182772
    [Abstract] [Full Text] [Related]

  • 32. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
    Chou LC, Yang JS, Huang LJ, Wu HC, Lu CC, Chiang JH, Chen KT, Kuo SC, Chung JG.
    J Gastroenterol; 2009 Apr 20; 44(10):1055-63. PubMed ID: 19688288
    [Abstract] [Full Text] [Related]

  • 33. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS, Lopez M, Carey RI, Lokeshwar BL.
    Int J Cancer; 2005 Jun 20; 115(3):484-92. PubMed ID: 15688368
    [Abstract] [Full Text] [Related]

  • 34. Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles.
    Jin MJ, Piao SJ, Jin TX, Jin ZH, Yin XZ, Gao ZG.
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb 20; 34(1):66-75. PubMed ID: 24496681
    [Abstract] [Full Text] [Related]

  • 35. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW, Lee DT, Chiu YT, Chua CW, Wang X, Wong YC.
    Int J Cancer; 2008 May 01; 122(9):1941-8. PubMed ID: 18183597
    [Abstract] [Full Text] [Related]

  • 36. [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells].
    Hao JW, Mao XP, Ding DG, Du GH, Liu ZH.
    Zhonghua Wai Ke Za Zhi; 2012 Feb 01; 50(2):161-5. PubMed ID: 22490358
    [Abstract] [Full Text] [Related]

  • 37. Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy.
    Sundaram S, Durairaj C, Kadam R, Kompella UB.
    Mol Cancer Ther; 2009 Jun 01; 8(6):1655-65. PubMed ID: 19509261
    [Abstract] [Full Text] [Related]

  • 38. Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
    Fabbri F, Brigliadori G, Carloni S, Ulivi P, Vannini I, Tesei A, Silvestrini R, Amadori D, Zoli W.
    J Transl Med; 2008 Aug 08; 6():43. PubMed ID: 18691406
    [Abstract] [Full Text] [Related]

  • 39. Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells.
    Mathur A, Abd Elmageed ZY, Liu X, Kostochka ML, Zhang H, Abdel-Mageed AB, Mondal D.
    PLoS One; 2014 Aug 08; 9(8):e103109. PubMed ID: 25121735
    [Abstract] [Full Text] [Related]

  • 40. Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells.
    Hwang JJ, Kim YS, Kim MJ, Kim DE, Jeong IG, Kim CS.
    J Urol; 2010 Dec 08; 184(6):2557-64. PubMed ID: 21030039
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.